COLLABORATIONS AND DEVELOPMENT FUNDAn essential part of the HARC Center will be to enlist a wide range of collaborators to help furtheridentify and validate HIV-host protein complexes, facilitate structure determination of the complexes, utilizestructural information to more deeply probe the biological functions of the HIV regulatory and accessoryproteins, and extend technological developments in high-throughput expression, structure determination, MSmethods, cryo-EM, and tomography. We will facilitate these essential collaborations by: actively reaching outto relevant researchers through direct contacts; organizing visits of collaborators and possible collaboratorsto the HARC Center to plan future research directions; providing seed funding for promising collaborations;facilitating funding opportunities for collaborators, including the related R21/R33 mechanism announced byNIAID; widely disseminating the goals, results, and available resources of the HARC Center to encouragefurther outside participation; and actively participating in national and international meetings. We haverequested 5% of the direct cost budget for a Collaboration Development Fund to support these activities.Given the breadth of projects encompassed in the initial establishment of the HARC Center, we havesolicited letters from potential collaborators working directly on the accessory and regulatory proteins andtechnologies that comprise the focus of this project. As the HARC Center becomes more established, newresearch directions will be evaluated thoroughly by the HARC Center Executive Council and internal andexternal advisory committees, and directions altered and funds allocated as appropriate. Our initialcollaborative efforts are described in more detail in Section IV.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-AARR-A (40))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
San Francisco
United States
Zip Code
Faust, Tyler B; Li, Yang; Bacon, Curtis W et al. (2018) The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation. Elife 7:
Eckhardt, Manon; Zhang, Wei; Gross, Andrew M et al. (2018) Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network. Cancer Discov 8:1474-1489
Masand, Ruchi; Paulo, Esther; Wu, Dongmei et al. (2018) Proteome Imbalance of Mitochondrial Electron Transport Chain in Brown Adipocytes Leads to Metabolic Benefits. Cell Metab 27:616-629.e4
Binning, Jennifer M; Smith, Amber M; Hultquist, Judd F et al. (2018) Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. PLoS Pathog 14:e1006830
Morris, Kyle L; Buffalo, Cosmo Z; Stürzel, Christina M et al. (2018) HIV-1 Nefs Are Cargo-Sensitive AP-1 Trimerization Switches in Tetherin Downregulation. Cell 174:659-671.e14
Chen, Si-Han; Jang, Gwendolyn M; Hüttenhain, Ruth et al. (2018) CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. EMBO J 37:
Leoz, Marie; Kukanja, Petra; Luo, Zeping et al. (2018) HEXIM1-Tat chimera inhibits HIV-1 replication. PLoS Pathog 14:e1007402
Cheng, Yifan (2018) Single-particle cryo-EM-How did it get here and where will it go. Science 361:876-880
Roth, Theodore L; Puig-Saus, Cristina; Yu, Ruby et al. (2018) Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559:405-409
Ferdin, Jana; Gori?ar, Katja; Dolžan, Vita et al. (2018) Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA. PLoS One 13:e0191613

Showing the most recent 10 out of 199 publications